help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 5, 2006, doi:10.1164/rccm.200512-1862OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200512-1862OCv1
175/1/9    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eikermann, M.
Right arrow Articles by Peters, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eikermann, M.
Right arrow Articles by Peters, J.
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 9-15, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200512-1862OC


Original Article

The Predisposition to Inspiratory Upper Airway Collapse during Partial Neuromuscular Blockade

Matthias Eikermann, Florian M. Vogt, Frank Herbstreit, Mehdi Vahid-Dastgerdi, Michael O. Zenge, Christof Ochterbeck, Armin de Greiff and Jürgen Peters

Klinik für Anästhesiologie und Intensivmedizin, and Klinik für Diagnostische Radiologie, Universitätsklinikum Essen; and Universität Duisburg-Essen, Essen, Germany

Correspondence and requests for reprints should be addressed to Priv. Doz. Dr. Matthias Eikermann, Oberarzt der Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Hufelandstrasse 55, D-45122 Essen, Germany. E-mail: meikermann{at}rics.bwh.harvard.edu

Rationale: Partial neuromuscular transmission failure by acetylcholine receptor blockade (neuromuscular blockade) or antibody-mediated functional loss (myasthenia gravis), even with a magnitude of muscle weakness that does not evoke respiratory symptoms, can evoke dysphagia and decreased inspiratory airflow, and increases the risk of susceptible patients to develop severe pulmonary complications.

Objectives: To assess whether impaired neuromuscular transmission predisposes individuals to inspiratory upper airway collapse, we assessed supraglottic airway diameter and volume by respiratory-gated magnetic resonance imaging, upper airway dilator muscle function (genioglossus force and EMG), and changes in lung volume, respiratory timing, and peripheral muscle function before, during, and after partial neuromuscular blockade in healthy, awake volunteers.

Measurements and Main Results: Partial neuromuscular blockade (train-of-four [TOF] ratio: 0.5 and 0.8) was associated with the following: (1) a decrease of inspiratory retropalatal and retroglossal upper airway volume to 66 ± 22 and 82 ± 12% of baseline, which was significantly more intense in the retropalatal area; (2) an attenuation of the normal increase in anteroposterior upper airway diameter during forced inspiration to 74 ± 18% of baseline; (3) a decrease in genioglossus activity during maximum voluntary tongue protrusion to 39 ± 19% (TOF, 0.5) and 73 ± 29% (TOF, 0.8) of baseline; and (4) no effects on upper airway size during expiration, lung volume, and respiratory timing.

Conclusions: Thus, impaired neuromuscular transmission, even to a degree insufficient to evoke respiratory symptoms, markedly impairs upper airway dimensions and function. This may be explained by an impairment of the balance between upper airway dilating forces and negative intraluminal pressure generated during inspiration by respiratory "pump" muscles.

Key Words: partial neuromuscular transmission failure • forced inspiration • upper airway size • upper airway dilator muscles • lung volume


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
It is unclear how important neuromuscular factors (in the absence of anatomic insufficiency) are in the pathogenesis of obstructive sleep apnea (OSA).

What This Study Adds to the Field
Our data show that impaired neuromuscular transmission, even to a degree insufficient to evoke respiratory symptoms, markedly impairs upper airway dimensions and function of the upper airway dilator muscles.

 



This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Eikermann, S. Zaremba, A. Malhotra, A. S. Jordan, C. Rosow, and N. L. Chamberlin
Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing
Br. J. Anaesth., September 1, 2008; 101(3): 344 - 349.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. C. Moore
Update in Asthma 2007
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1068 - 1073.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008